Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 01 2020
accepted: 29 07 2020
pubmed: 2 8 2020
medline: 26 1 2021
entrez: 2 8 2020
Statut: ppublish

Résumé

Omics-based methods may provide new markers associated to diabetic retinopathy (DR). We investigated a wide omics panel of metabolites and lipids related to DR in type 1 diabetes. Metabolomic analyses were performed using two-dimensional gas chromatography with time-of-flight mass spectrometry and lipidomic analyses using an ultra-high-performance liquid chromatography quadruple time-of-flight mass spectrometry method in 648 individuals with type 1 diabetes. Subjects were subdivided into no DR, mild nonproliferative DR (NPDR), moderate NPDR, proliferative DR, and proliferative DR with fibrosis. End points were any progression of DR, onset of DR, and progression from mild to severe DR tracked from standard ambulatory care and investigated using Cox models. The cohort consisted of 648 participants aged a mean of 54.4 ± 12.8 years, 55.5% were men, and follow-up was 5.1-5.5 years. Cross-sectionally, 2,4-dihydroxybutyric acid (DHBA), 3,4-DHBA, ribonic acid, ribitol, and the triglycerides 50:1 and 50:2 significantly correlated (

Identifiants

pubmed: 32737117
pii: db20-0104
doi: 10.2337/db20-0104
pmc: PMC7506826
doi:

Substances chimiques

Triglycerides 0

Banques de données

figshare
['10.2337/figshare.12733202']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2217-2226

Informations de copyright

© 2020 by the American Diabetes Association.

Références

Ann Neurol. 2003;54 Suppl 6:S73-80
pubmed: 12891657
Front Endocrinol (Lausanne). 2019 Nov 22;10:818
pubmed: 31824430
Sci Rep. 2019 Nov 8;9(1):16398
pubmed: 31705008
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3119-3126
pubmed: 31323682
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Sci Rep. 2019 Jun 24;9(1):9191
pubmed: 31235863
Diabetes. 1977 Mar;26(3):215-21
pubmed: 838172
Transl Psychiatry. 2017 Sep 26;7(9):e1240
pubmed: 28949339
J Mach Learn Res. 2012 Apr;13:1059-1062
pubmed: 26834510
Am J Nephrol. 2016;44(2):92-103
pubmed: 27410520
Exp Eye Res. 1991 May;52(5):569-73
pubmed: 2065725
Mol Biosyst. 2011 Jul;7(7):2228-37
pubmed: 21559540
Nat Rev Drug Discov. 2005 Jul;4(7):594-610
pubmed: 16052242
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):51-4
pubmed: 25450817
Magn Reson Imaging. 2014 Oct;32(8):1037-42
pubmed: 24985566
Ophthalmology. 2010 Jan;117(1):63-70
pubmed: 19880184
Cell. 2014 Oct 9;159(2):318-32
pubmed: 25303528
Biochem Biophys Res Commun. 2006 Jan 20;339(3):816-20
pubmed: 16332355
Oxid Med Cell Longev. 2019 Mar 6;2019:8458472
pubmed: 30962865
Cardiovasc Psychiatry Neurol. 2011;2011:609202
pubmed: 21350721
Anal Chem. 2011 Apr 15;83(8):3058-67
pubmed: 21434611
N Engl J Med. 2010 Jul 15;363(3):233-44
pubmed: 20587587
Biostatistics. 2008 Jul;9(3):432-41
pubmed: 18079126
Acta Diabetol. 2014 Dec;51(6):973-80
pubmed: 25274394
Diabetes. 1997 Jan;46(1):3-10
pubmed: 8971073
Rev Diabet Stud. 2015 Spring-Summer;12(1-2):159-95
pubmed: 26676667
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Diabetologia. 1999 Feb;42(2):128-38
pubmed: 10064091
J Proteome Res. 2018 Jun 1;17(6):2131-2143
pubmed: 29671324
Diabetes. 2010 Jul;59(7):1780-8
pubmed: 20424229
Lancet. 2007 Nov 17;370(9600):1687-97
pubmed: 17988728
Cell Physiol Biochem. 2018;48(3):1317-1331
pubmed: 30048968
Exp Eye Res. 1990 Jun;50(6):567-73
pubmed: 2115448
Nutrients. 2020 May 07;12(5):
pubmed: 32392758
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
Diabetes. 2016 Apr;65(4):1099-108
pubmed: 26822086
Trends Endocrinol Metab. 2015 Dec;26(12):671-673
pubmed: 26439978
Nutr Metab (Lond). 2019 May 28;16:37
pubmed: 31160916
J Clin Med. 2019 Jun 19;8(6):
pubmed: 31248127
BMC Bioinformatics. 2010 Jul 23;11:395
pubmed: 20650010

Auteurs

Viktor Rotbain Curovic (VR)

Steno Diabetes Center Copenhagen, Gentofte, Denmark viktor.rotbain.curovic@regionh.dk.

Tommi Suvitaival (T)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Ismo Mattila (I)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Linda Ahonen (L)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Kajetan Trošt (K)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Simone Theilade (S)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Tine W Hansen (TW)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Cristina Legido-Quigley (C)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, London, U.K.

Peter Rossing (P)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.
University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH